Avricore Health Inc.
AVCR.V
TSX
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -89.45% | -96.87% | -97.29% | -97.29% | -63.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -89.45% | -96.87% | -97.29% | -97.29% | -63.74% |
| Cost of Revenue | -37.91% | -88.25% | -88.74% | -88.74% | -87.10% |
| Gross Profit | -102.57% | -111.98% | -112.84% | -112.84% | -32.90% |
| SG&A Expenses | -44.17% | -46.54% | 32.77% | 32.77% | 26.82% |
| Depreciation & Amortization | 287.50% | 100.00% | 60.00% | 60.00% | 60.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -42.32% | -69.95% | -51.34% | -51.34% | -50.19% |
| Operating Income | -261.06% | -136.90% | -727.55% | -727.55% | -135.53% |
| Income Before Tax | -173.28% | -109.75% | -940.00% | -940.00% | -143.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -173.28% | -109.75% | -940.00% | -940.00% | -143.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -173.28% | -109.75% | -940.00% | -940.00% | -143.12% |
| EBIT | -261.06% | -136.90% | -727.55% | -727.55% | -135.53% |
| EBITDA | -698.99% | -714.04% | -321.27% | -321.27% | -109.27% |
| EPS Basic | -200.00% | -107.69% | -925.00% | -925.00% | -138.46% |
| Normalized Basic EPS | -200.00% | -112.50% | -1,100.00% | -1,100.00% | -142.86% |
| EPS Diluted | -200.00% | -107.69% | -925.00% | -925.00% | -138.46% |
| Normalized Diluted EPS | -200.00% | -112.50% | -1,100.00% | -1,100.00% | -142.86% |
| Average Basic Shares Outstanding | 0.00% | 0.89% | 1.42% | 1.42% | 1.55% |
| Average Diluted Shares Outstanding | 0.00% | 0.89% | -4.09% | -4.09% | 1.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |